2C-T-13

Last updated

2C-T-13
2C-T-13.svg
2C-T-13-3d-sticks.png
Clinical data
Other names4-(2-Methoxyethylthio)-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-(2-methoxyethylthio)phenethylamine
Routes of
administration 		Oral [1]
Drug class Serotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of action 6–8 hours [1]
Identifiers
  • 2-{{#parsoidfragment:2}}{2,5-dimethoxy-4-[(2-methoxyethyl)sulfanyl]phenyl}ethan-1-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
Formula C13H21NO3S
Molar mass 271.38 g·mol−1
3D model (JSmol)
  • COc1cc(SCCOC)c(cc1CCN)OC
  • InChI=1S/C13H21NO3S/c1-15-6-7-18-13-9-11(16-2)10(4-5-14)8-12(13)17-3/h8-9H,4-7,14H2,1-3H3 Yes check.svgY
  • Key:PYJLRNOGMKMRTK-UHFFFAOYSA-N Yes check.svgY
 X mark.svgNYes check.svgY  (what is this?)    (verify)

2C-T-13, also known as 4-(2-methoxyethylthio)-2,5-dimethoxyphenethylamine, is a psychedelic phenethylamine of the 2C family. It was presumably first synthesized by Alexander Shulgin and reported in his book PiHKAL . [1]

Contents

Use and effects

The dose range of 2C-T-13 is 25 to 40 mg and its duration is approximately 6 to 8 hours according to Alexander Shulgin. [1] 2C-T-13 produces many closed-eye visuals and geometric patterns. It also produces slight visual distortion. [1]

Interactions

Chemistry

The drug has structural properties similar to mescaline and other drugs in the 2C-T series, with the most closely related compounds being 2C-T-7 and 2C-T-21. [1]

History

2C-T-13 was first described in the scientific literature by Alexander Shulgin and colleagues in 1991. [2] Subsequently, it was described in greater detail by Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved). [1]

Society and culture

Canada

As of October 31, 2016, 2C-T-13 is a controlled substance (Schedule III) in Canada. [3]

United States

2C-T-13 is not scheduled in the United States, but possession and sales of 2C-T-13 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.

See also

References

  1. 1 2 3 4 5 6 7 PiHKAL #46 2C-T-13
  2. ↑ Shulgin AT, Shulgin A, Jacob P (January 1991). "Central nervous system (CNS) activity of two new psychoactive compounds". Journal of Psychoactive Drugs. 23 (1): 95–96. doi:10.1080/02791072.1991.10472583. eISSN   2159-9777. PMID   1941371. Archived from the original on 2025-07-13.
  3. ↑ "Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". 4 May 2016.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.